Regenerative medicine · Built to scale nationally
Aethera is building a national network of integrated clinics — cellular medicine, neurological wellness, IV therapy and human performance — on a CLIA diagnostics backbone and IRB-governed research. One protocol-driven brand, many cities.
Aethera Cellular Medicine sits at the center of it all — a family of specialized brands, each built or absorbed into one integrated platform. Click any company to see it for yourself.
Fulcrum Performancemidtownbiohack.com
RediCell Biologicsredicell.com
SelfHealthselfhealth.health
JIV Drip Barjustivclinics.com
NeuroRenewneurorenewclinics.comDeveloped with Dr. Richard Miller · 2 clinics
RegenHealthrhpny.comOur base working model
Click any logo above to open that company’s website in a new tab.
Clinicians and operators who have opened clinics, trained physicians, governed research and built the technology — now doing it under one brand.
Full biographies are in the investor portal.
Every Aethera clinic runs the same integrated stack — so a patient who walks in for one service is met by a whole platform, and every site becomes a research node.
Physician-led regenerative and cellular therapies — joint, orthopedic and longevity protocols under IRB governance.
rhpny.com →Our example clinic — the working model Aethera is built from.
Peripheral-neuropathy and functional-neurology programs — laser and light therapy, an underserved specialty.
neurorenewclinics.com →Already developed with Dr. Richard Miller.
Physician-supervised IV therapy and recovery — the welcoming front door into the clinical platform.
justivclinics.com →
Human-performance coaching on patented NovaKey™ and SSBreath™ monitoring technology.
midtownbiohack.com →
On-site specialized panels at every clinic, including the StemAge™ biological-age test — turning routine care into longitudinal data.
selfhealth.health →IRB-governed sites with lab chain-of-custody generate trials, publications and IP that no single clinic can produce.
Physician-directed regenerative and hormone medicine — autologous procedures, cellular and exosome therapies, peptides and performance medicine. Every therapy we offer is listed below with its United States regulatory status stated alongside it.
Physician-directed regenerative protocols
Cell-free signaling — not FDA-approved
Targeted recovery & longevity
Fulcrum NovaKey™ + SSBreath™
Scientific illustrations for orientation. All therapies are physician-directed and provided only following individual clinical evaluation. Each therapy’s United States regulatory status is stated in the menu below.
Aethera Cellular Medicine offers the therapies below. Each one carries its United States regulatory status, because the distinction is real and most clinics do not draw it.
Regulatory disclosure. Every therapy above is provided only after individual evaluation by a licensed clinician. Nothing on this page is medical advice, an offer to treat any disease or condition, or a promise of any result; individual results vary. FDA-approved medicines are approved for specific indications, and any use outside those indications is an off-label clinical decision made with your prescriber. Procedures performed with FDA-cleared equipment are not themselves FDA-approved or FDA-cleared treatments — the FDA clears the device, not the therapy, and clearing a device is not a finding that a procedure using it is safe or effective for the condition being treated. Compounded preparations are not FDA-approved and are not reviewed by the FDA for safety, effectiveness or quality. The therapies listed as Not FDA-approved have not been reviewed by the FDA for safety or effectiveness for any use; they are regulated as unapproved new drugs and unlicensed biological products, and are provided only following a documented informed-consent discussion. Registration of a facility, laboratory or pharmacy with the FDA is not FDA approval or clearance of anything it makes. Regulatory statements on this page are current as of 29 August 2026 and are reviewed at least annually.
In Greek mythology, aether was the pure air above the clouds — the one only the gods breathed, untouched by decay. Aethera borrows the name because the science works on the same idea: give damaged tissue a cleaner biological environment and it repairs itself. That's what our exosome and cellular therapies are designed to do. Not a metaphor. A treatment philosophy.
Luminous vitality. Regenerative science.One clinic per city, opening in pairs — five launch markets already scoped, five expansion cities in active site selection, plus satellite locations in select hotels and gyms and a flagship wellness center to follow.
Aethera stands on operating clinics, a global biologics platform, chain-of-custody labs and elite performance IP that already exist today.
The live, operating clinics our founding team helped build — the validated model Aethera scales nationally.
rhpny.com →
A global regenerative platform — biologics, MSC-derived exosome and peptide science powering Aethera Cellular Medicine.
auvum.bio →
Regenerative biologics supplier to the network, advancing a partnership with the ACC bioaccelerator — deployed in Aethera clinics under USMLE100-governed protocols.
redicell.com →Elite human-performance protocols on patented NovaKey™ and SSBreath™ technology — the Fulcrum program at Midtown Biohack.
midtownbiohack.com →
To express our gratitude, every investor in this round may purchase the Founders' Package — a $45,000 allowance for physician-directed regenerative treatment, for $15,000. Deliberately kept out of the financial model.
Apply the allowance across treatment types; once you choose a focus, the treating physician provides individualized guidance. Optional and entirely separate from the investment. Offered at closing; activates when the first Aethera clinic in your chosen city opens; usable over 24 months and applicable to immediate family; full refund if no clinic opens within 18 months.
The Founders' Package is an optional purchase of clinical services offered in gratitude to participating investors. It is not a security, is not part of the securities offering, is not a return on investment, and no clinical outcome is guaranteed. All care is physician-directed following individual evaluation.
Whether you're a future patient, a potential partner, or an investor — tell us how you'd like to connect.
Investor materials are confidential and provided only to qualified, invited recipients under Reg D 506(b). This page is informational and not an offer to sell securities.
